Chapter/Section Purchase

1 Study Coverage
1.1 Phosphodiesterase (PDE) inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global Phosphodiesterase (PDE) inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PDE1 Selective Inhibitors
1.2.3 PDE2 Selective Inhibitors
1.2.4 PDE3 Selective Inhibitors
1.2.5 PDE4 selective inhibitors
1.2.6 PDE5 selective inhibitors
1.2.7 PDE7 selective inhibitors
1.2.8 PDE10 selective inhibitors
1.3 Market by Application
1.3.1 Global Phosphodiesterase (PDE) inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oral
1.3.3 Topical
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Phosphodiesterase (PDE) inhibitors Sales Estimates and Forecasts 2017-2028
2.2 Global Phosphodiesterase (PDE) inhibitors Revenue Estimates and Forecasts 2017-2028
2.3 Global Phosphodiesterase (PDE) inhibitors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Phosphodiesterase (PDE) inhibitors Sales by Region
2.4.1 Global Phosphodiesterase (PDE) inhibitors Sales by Region (2017-2022)
2.4.2 Global Sales Phosphodiesterase (PDE) inhibitors by Region (2023-2028)
2.5 Global Phosphodiesterase (PDE) inhibitors Revenue by Region
2.5.1 Global Phosphodiesterase (PDE) inhibitors Revenue by Region (2017-2022)
2.5.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Phosphodiesterase (PDE) inhibitors Sales by Manufacturers
3.1.1 Global Top Phosphodiesterase (PDE) inhibitors Manufacturers by Sales (2017-2022)
3.1.2 Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Phosphodiesterase (PDE) inhibitors in 2021
3.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Manufacturers
3.2.1 Global Phosphodiesterase (PDE) inhibitors Revenue by Manufacturers (2017-2022)
3.2.2 Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Phosphodiesterase (PDE) inhibitors Revenue in 2021
3.3 Global Phosphodiesterase (PDE) inhibitors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Phosphodiesterase (PDE) inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Phosphodiesterase (PDE) inhibitors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Phosphodiesterase (PDE) inhibitors Sales by Type
4.1.1 Global Phosphodiesterase (PDE) inhibitors Historical Sales by Type (2017-2022)
4.1.2 Global Phosphodiesterase (PDE) inhibitors Forecasted Sales by Type (2023-2028)
4.1.3 Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2017-2028)
4.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Type
4.2.1 Global Phosphodiesterase (PDE) inhibitors Historical Revenue by Type (2017-2022)
4.2.2 Global Phosphodiesterase (PDE) inhibitors Forecasted Revenue by Type (2023-2028)
4.2.3 Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type (2017-2028)
4.3 Global Phosphodiesterase (PDE) inhibitors Price by Type
4.3.1 Global Phosphodiesterase (PDE) inhibitors Price by Type (2017-2022)
4.3.2 Global Phosphodiesterase (PDE) inhibitors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Phosphodiesterase (PDE) inhibitors Sales by Application
5.1.1 Global Phosphodiesterase (PDE) inhibitors Historical Sales by Application (2017-2022)
5.1.2 Global Phosphodiesterase (PDE) inhibitors Forecasted Sales by Application (2023-2028)
5.1.3 Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2017-2028)
5.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Application
5.2.1 Global Phosphodiesterase (PDE) inhibitors Historical Revenue by Application (2017-2022)
5.2.2 Global Phosphodiesterase (PDE) inhibitors Forecasted Revenue by Application (2023-2028)
5.2.3 Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Application (2017-2028)
5.3 Global Phosphodiesterase (PDE) inhibitors Price by Application
5.3.1 Global Phosphodiesterase (PDE) inhibitors Price by Application (2017-2022)
5.3.2 Global Phosphodiesterase (PDE) inhibitors Price Forecast by Application (2023-2028)
6 North America
6.1 North America Phosphodiesterase (PDE) inhibitors Market Size by Type
6.1.1 North America Phosphodiesterase (PDE) inhibitors Sales by Type (2017-2028)
6.1.2 North America Phosphodiesterase (PDE) inhibitors Revenue by Type (2017-2028)
6.2 North America Phosphodiesterase (PDE) inhibitors Market Size by Application
6.2.1 North America Phosphodiesterase (PDE) inhibitors Sales by Application (2017-2028)
6.2.2 North America Phosphodiesterase (PDE) inhibitors Revenue by Application (2017-2028)
6.3 North America Phosphodiesterase (PDE) inhibitors Market Size by Country
6.3.1 North America Phosphodiesterase (PDE) inhibitors Sales by Country (2017-2028)
6.3.2 North America Phosphodiesterase (PDE) inhibitors Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Phosphodiesterase (PDE) inhibitors Market Size by Type
7.1.1 Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2017-2028)
7.1.2 Europe Phosphodiesterase (PDE) inhibitors Revenue by Type (2017-2028)
7.2 Europe Phosphodiesterase (PDE) inhibitors Market Size by Application
7.2.1 Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2017-2028)
7.2.2 Europe Phosphodiesterase (PDE) inhibitors Revenue by Application (2017-2028)
7.3 Europe Phosphodiesterase (PDE) inhibitors Market Size by Country
7.3.1 Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2017-2028)
7.3.2 Europe Phosphodiesterase (PDE) inhibitors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Phosphodiesterase (PDE) inhibitors Market Size by Type
8.1.1 Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Type (2017-2028)
8.1.2 Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Type (2017-2028)
8.2 Asia Pacific Phosphodiesterase (PDE) inhibitors Market Size by Application
8.2.1 Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Application (2017-2028)
8.2.2 Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Application (2017-2028)
8.3 Asia Pacific Phosphodiesterase (PDE) inhibitors Market Size by Region
8.3.1 Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Region (2017-2028)
8.3.2 Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Phosphodiesterase (PDE) inhibitors Market Size by Type
9.1.1 Latin America Phosphodiesterase (PDE) inhibitors Sales by Type (2017-2028)
9.1.2 Latin America Phosphodiesterase (PDE) inhibitors Revenue by Type (2017-2028)
9.2 Latin America Phosphodiesterase (PDE) inhibitors Market Size by Application
9.2.1 Latin America Phosphodiesterase (PDE) inhibitors Sales by Application (2017-2028)
9.2.2 Latin America Phosphodiesterase (PDE) inhibitors Revenue by Application (2017-2028)
9.3 Latin America Phosphodiesterase (PDE) inhibitors Market Size by Country
9.3.1 Latin America Phosphodiesterase (PDE) inhibitors Sales by Country (2017-2028)
9.3.2 Latin America Phosphodiesterase (PDE) inhibitors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size by Type
10.1.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Type (2017-2028)
10.1.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Type (2017-2028)
10.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size by Application
10.2.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Application (2017-2028)
10.2.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Application (2017-2028)
10.3 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size by Country
10.3.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2017-2028)
10.3.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Overview
11.1.3 Bayer AG Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer AG Phosphodiesterase (PDE) inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer AG Recent Developments
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Corporation Information
11.2.2 Eli Lilly and Co. Overview
11.2.3 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly and Co. Recent Developments
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Corporation Information
11.3.2 GlaxoSmithKline Plc Overview
11.3.3 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Plc Recent Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Corporation Information
11.4.2 Pfizer Inc. Overview
11.4.3 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Inc. Recent Developments
11.5 Vivus Inc.
11.5.1 Vivus Inc. Corporation Information
11.5.2 Vivus Inc. Overview
11.5.3 Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Vivus Inc. Phosphodiesterase (PDE) inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Vivus Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Phosphodiesterase (PDE) inhibitors Industry Chain Analysis
12.2 Phosphodiesterase (PDE) inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Phosphodiesterase (PDE) inhibitors Production Mode & Process
12.4 Phosphodiesterase (PDE) inhibitors Sales and Marketing
12.4.1 Phosphodiesterase (PDE) inhibitors Sales Channels
12.4.2 Phosphodiesterase (PDE) inhibitors Distributors
12.5 Phosphodiesterase (PDE) inhibitors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Phosphodiesterase (PDE) inhibitors Industry Trends
13.2 Phosphodiesterase (PDE) inhibitors Market Drivers
13.3 Phosphodiesterase (PDE) inhibitors Market Challenges
13.4 Phosphodiesterase (PDE) inhibitors Market Restraints
14 Key Findings in The Global Phosphodiesterase (PDE) inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer